This project investigates whether biomarkers in serum, cerebrospinal fluid, or on brain imaging can predict neurotoxicity risk and measure brain injury in pediatric cancer immunotherapy patients.
We study the effects of CD19-directed CAR T cell therapy on the brain microvasculature in an immunocompetent mouse model.
By clicking “Accept All Cookies,” you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in marketing efforts. For more information, see Website Privacy.